DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Q1 2025 13F Holdings
- Locationnew york, NY
- Num holdings
123
- Value ($000)
$5,064,779
- Date Filed05/15/2025
- Form type13F-HR
- CIK0001009258
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
NUVL NUVALENT INC | COM | 670703107 | $1.28B | 25 % | 17,991,024 | ||
VTRS VIATRIS INC | COM | 92556V106 | $208.97M | 4 % | 23,991,594 | ||
IART 0.5 08/15/25 INTEGRA LIFESCIENCES HLDGS C | NOTE 0.500% 8/1 | 457985AM1 | $170.98M | 3 % | 174,364,000 | ||
NBIX NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | $164.68M | 3 % | 1,489,000 | ||
CNC CENTENE CORP DEL | COM | 15135B101 | $162.21M | 3 % | 2,671,921 | ||
OSCR OSCAR HEALTH INC | CL A | 687793109 | $155.23M | 3 % | 11,840,818 | ||
MERUS N V | COM | N5749R100 | $133.59M | 3 % | 3,173,928 | ||
ARS PHARMACEUTICALS INC | COM | 82835W108 | $132.27M | 3 % | 10,514,657 | ||
ACCD 0.5 04/01/26 ACCOLADE INC | NOTE 0.500% 4/0 | 00437EAB8 | $130.63M | 3 % | 132,598,000 | ||
ALNY 1 09/15/27 ALNYLAM PHARMACEUTICALS INC | NOTE 1.000% 9/1 | 02043QAB3 | $126.87M | 3 % | 110,000,000 |
Rows Per Page
10
- 10
- 50
- 100